Among them, bladder urothelial carcinoma, cholangiocarcinoma, breast invasive carcinoma, COAD, EAC, KIRP, LUSC, PRAD, GBM, HINSC, LIHC, STAD, and UCEC all showed significant levels of DLL3 expression. Here, CYLD is linked to invasive breast carcinoma.